P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting

BACKGROUND: The broad use of immunosuppressants and biologicals in Inflammatory Bowel Disease (IBD) patients increases the susceptibility to severe infections, and possibly COVID-19. Recently, in a Swedish population-based study it was suggested that IBD patients are at an increased risk of hospital...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Crohns Colitis
Hauptverfasser: Rezazadeh Ardabili, A, Creemers, R H, Jonkers, D M A E, Romberg-Camps, M J L, Pierik, M J, van Bodegraven, A A
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Poster Presentations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194845/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab076.757
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge